Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Utah Medical Products (UTMD) Income towards Parent Company (2016 - 2025)

Utah Medical Products has reported Income towards Parent Company over the past 16 years, most recently at -$9.2 million for Q4 2025.

  • Quarterly results put Income towards Parent Company at -$9.2 million for Q4 2025, down 1454.21% from a year ago — trailing twelve months through Dec 2025 was -$512000.0 (down 104.93% YoY), and the annual figure for FY2025 was -$512000.0, down 104.93%.
  • Income towards Parent Company for Q4 2025 was -$9.2 million at Utah Medical Products, down from $2.6 million in the prior quarter.
  • Over the last five years, Income towards Parent Company for UTMD hit a ceiling of $4.3 million in Q3 2022 and a floor of -$9.2 million in Q4 2025.
  • Median Income towards Parent Company over the past 5 years was $3.4 million (2021), compared with a mean of $1.6 million.
  • Biggest five-year swings in Income towards Parent Company: skyrocketed 160.93% in 2021 and later crashed 1454.21% in 2025.
  • Utah Medical Products' Income towards Parent Company stood at -$2.6 million in 2021, then plummeted by 37.72% to -$3.6 million in 2022, then crashed by 106.81% to -$7.5 million in 2023, then skyrocketed by 92.09% to -$594000.0 in 2024, then crashed by 1454.21% to -$9.2 million in 2025.
  • The last three reported values for Income towards Parent Company were -$9.2 million (Q4 2025), $2.6 million (Q3 2025), and $3.0 million (Q2 2025) per Business Quant data.